Literature DB >> 20372925

Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species.

Daniel B Liarte1, Silvane M F Murta.   

Abstract

In the present study, we selected in vitro populations of Leishmania Viannia guyanensis, L.V. braziliensis, L. Leishmania amazonensis and L.L. infantum chagasi that were resistant to potassium antimony tartrate (SbIII). The resistance index of these populations varied from 4- to 20-fold higher than that of their wild-type counterparts. To evaluate the stability of the resistance phenotype, these four resistant populations were passaged 37 to 47 times in a culture medium without SbIII. No change was observed in the resistance indexes of L.V. guyanensis (19-fold) and L.L. infantum chagasi (4-fold). In contrast, a decrease in the resistance index was observed for L.V. braziliensis (from 20- to 10-fold) and L.L. amazonensis (from 6- to 3-fold). None of the antimony-resistant populations exhibited cross-resistance to amphotericin B and miltefosine. However, the resistant populations of L.V. braziliensis, L.L. amazonensis and L.L. infantum chagasi were also resistant to paromomycin. A drastic reduction was observed in the infectivity in mice for the resistant L.V. guyanensis, L.L. amazonensis and L.V. braziliensis populations. The SbIII-resistant phenotype of L.V. braziliensis was stable after one passage in mice. Although the protocol of induction was the same, the SbIII-resistant populations showed different degrees of tolerance, stability, infectivity in mice and cross-resistance to antileishmanial drugs, depending on the Leishmania species.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372925     DOI: 10.1007/s00436-010-1852-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  45 in total

1.  Structural and functional analysis of an amplification containing a PGPA gene in a glucantime-resistant Leishmania (Viannia) guyanensis cell line.

Authors:  Charles Anacleto; Maria C B Abdo; Adlane V B Ferreira; Silvane M F Murta; Alvaro J Romanha; Ana Paula Fernandes; Elizabeth S A Moreira
Journal:  Parasitol Res       Date:  2003-02-11       Impact factor: 2.289

2.  Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin.

Authors:  M L Cunningham; R G Titus; S J Turco; S M Beverley
Journal:  Science       Date:  2001-04-13       Impact factor: 47.728

Review 3.  Mucosal leishmaniasis ("espundia" Escomel, 1911).

Authors:  P D Marsden
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

4.  pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum.

Authors:  Rhys Hayward; Kevin J Saliba; Kiaran Kirk
Journal:  Mol Microbiol       Date:  2005-02       Impact factor: 3.501

Review 5.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

6.  Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani.

Authors:  Susan Wyllie; Mark L Cunningham; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

7.  Secondary mutations correct fitness defects in Toxoplasma gondii with dinitroaniline resistance mutations.

Authors:  Christopher Ma; Johnson Tran; Catherine Li; Lakshmi Ganesan; David Wood; Naomi Morrissette
Journal:  Genetics       Date:  2008-09-09       Impact factor: 4.562

8.  Rapid fluorescent assay for screening drugs on Leishmania amastigotes.

Authors:  Orly Shimony; Charles L Jaffe
Journal:  J Microbiol Methods       Date:  2008-06-05       Impact factor: 2.363

9.  Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani.

Authors:  Christian Bories; Sandrine Cojean; Françoise Huteau; Philippe M Loiseau
Journal:  Biomed Pharmacother       Date:  2008-01-14       Impact factor: 6.529

10.  Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections.

Authors:  Jacobus C de Roode; Richard Culleton; Andrew S Bell; Andrew F Read
Journal:  Malar J       Date:  2004-09-14       Impact factor: 2.979

View more
  19 in total

1.  Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.

Authors:  Juvana M Andrade; Elio H Baba; Ricardo A Machado-de-Avila; Carlos Chavez-Olortegui; Cynthia P Demicheli; Frédéric Frézard; Rubens L Monte-Neto; Silvane M F Murta
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates.

Authors:  Johannes Austrup; Pantelis Ntais; Vasiliki Christodoulou; Jean-Pierre Dedet; Francine Pratlong; Maria Antoniou
Journal:  Parasitol Res       Date:  2014-02-07       Impact factor: 2.289

Review 3.  Leishmania antimony resistance: what we know what we can learn from the field.

Authors:  Khatima Aït-Oudhia; Elodie Gazanion; Baptiste Vergnes; Bruno Oury; Denis Sereno
Journal:  Parasitol Res       Date:  2011-07-29       Impact factor: 2.289

4.  Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis.

Authors:  Rubens L do Monte-Neto; Adriano C Coelho; Frédéric Raymond; Danielle Légaré; Jacques Corbeil; Maria N Melo; Frédéric Frézard; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

5.  Leishmania aethiopica field isolates bearing an endosymbiontic dsRNA virus induce pro-inflammatory cytokine response.

Authors:  Haroun Zangger; Asrat Hailu; Chantal Desponds; Lon-Fye Lye; Natalia S Akopyants; Deborah E Dobson; Catherine Ronet; Hashim Ghalib; Stephen M Beverley; Nicolas Fasel
Journal:  PLoS Negl Trop Dis       Date:  2014-04-24

Review 6.  Comparative analysis of the omics technologies used to study antimonial, amphotericin B, and pentamidine resistance in leishmania.

Authors:  Gagandeep Kaur; Bhawana Rajput
Journal:  J Parasitol Res       Date:  2014-05-12

7.  Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility.

Authors:  Ana Maria Murta Santi; Paula Alves Silva; Isabella Fernandes Martins Santos; Silvane Maria Fonseca Murta
Journal:  Parasit Vectors       Date:  2021-07-15       Impact factor: 3.876

8.  A nanoemulsion-based nanogel of Citrus limon essential oil with leishmanicidal activity against Leishmania tropica and Leishmania major.

Authors:  Elham Zarenezhad; Mahmoud Agholi; Ali Ghanbariasad; Ali Ranjbar; Mahmoud Osanloo
Journal:  J Parasit Dis       Date:  2020-11-19

9.  Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony.

Authors:  Douglas S Moreira; Rubens L Monte Neto; Juvana M Andrade; Ana Maria M Santi; Priscila G Reis; Frédéric Frézard; Silvane M F Murta
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-09-05       Impact factor: 4.077

10.  Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum lines.

Authors:  Juvana M Andrade; Silvane M F Murta
Journal:  Parasit Vectors       Date:  2014-08-29       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.